Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Dipesh Navsaria MPH, MSLIS, MD
Dipesh Navsaria MPH, MSLIS, MD Advisory Board
Irene Hamrick MD, FAAFP, AGSF, CMD
Irene Hamrick MD, FAAFP, AGSF, CMD Advisory Board
David Rakel MD, FAAFP
David Rakel MD, FAAFP Editor-in-Chief
See All Experts
Published in Primary Care

Journal Scan / Research · September 20, 2022

Efficacy and Safety of Dolutegravir vs Current HIV Regimens in Pregnant Women in the US

The New England Journal of Medicine

 

 Save  Recommend
 Share

Additional Info

The New England Journal of Medicine
Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States
N. Engl. J. Med 2022 Sep 01;387(9)799-809, K Patel, Y Huo, J Jao, KM Powis, PL Williams, D Kacanek, LM Yee, EG Chadwick, S Shiau, DL Jacobson, SS Brummel, L Sultan-Beyer, CR Kahlert, R Zash, GR Seage

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated